Analysis Group and Hyman, Phelps & McNamara, P.C. to Host Webinar on Controlled Substances Act Issues
Event:Controlled Substances Act Issues: Legal Perspectives and Analytical Trends Webinar
Date:
April 27, 2021
Host:
Hyman, Phelps & McNamara, P.C. and Analysis Group
Times:
11:00 a.m.–1:00 p.m. (PT) / 2:00–4:00 p.m. (ET)
Analysis Group and Hyman, Phelps & McNamara, P.C. are partnering to host a three-topic timely, informative, and free program to discuss current important legal perspectives and analytical trends concerning the Controlled Substances Act and the Drug Enforcement Administration (DEA). Topics will include a discussion on recent DEA regulatory changes, the legal and regulatory requirements for pharmacists, and the proposed SOM rule and distribution trends. Speakers will include Managing Principal Crystal Pike, Vice President Kenneth Weinstein, and Manager Nicholas Van Niel from Analysis Group and John A. Gilbert, Jr., Karla L. Palmer, and Larry K. Houck from Hyman, Phelps & McNamara. To RSVP for this program, please email Amy Vasvary at avasvary@hpm.com.
State of the Agency: Recent Drug Enforcement Administration Regulatory Changes (2:00–2:40 p.m. ET)
John A. Gilbert, Jr. and Crystal Pike
The Pharmacist’s Corresponding Responsibility: Legal and Regulatory Requirements and Recent Enforcement Activity (2:40–3:20 p.m. ET)
Karla L. Palmer and Nicholas Van Niel
“Suspicious Order” Monitoring: The SUPPORT Act, Proposed SOM Rule, the “ORUSC,” and Distribution Trends (3:20–4:00 p.m. ET)
Larry K. Houck and Kenneth Weinstein